Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

American pharmaceutical duo injects an additional 150 million dollars into Ghent megasite for cancer therapy

Summary by De Tijd
Johnson & Johnson and Legend Biotech are investing in expanding their mega-production site for blood cancer therapy in Ghent to keep up with demand. It concerns an amount of 150 million dollars (138 million euros).
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

De TijdDe Tijd

American pharmaceutical duo injects an additional 150 million dollars into Ghent megasite for cancer therapy

Johnson & Johnson and Legend Biotech are investing in expanding their mega-production site for blood cancer therapy in Ghent to keep up with demand. It concerns an amount of 150 million dollars (138 million euros).

·Belgium
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

De Tijd broke the news in Belgium on Thursday, March 13, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Ghent icon

Ghent

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal